Literature DB >> 22374292

Thymectomy for thymoma and myasthenia gravis. A survey of current surgical practice in thymic disease amongst EACTS members.

Marco Lucchi1, Paul Van Schil, Ralph Schmid, Federico Rea, Franca Melfi, Kalliopi Athanassiadi, Marcin Zielinski, Tom Treasure.   

Abstract

Thymic disorders, both oncological and non-oncological, are rare. Multi-institutional, randomized studies are currently not available. The Thymic Working Group of the European Association for Cardio-Thoracic Surgery (EACTS) decided to perform a survey aiming to estimate the extent and type of current surgical practice in thymic diseases. A questionnaire was addressed to the thoracic and cardio-thoracic members of the society, and the answers received from 114 participants were analysed. High-volume surgeons cooperate more frequently with a dedicated neurologist and anaesthesist (P = 0.04), determine more frequently neurological scores pre- and postoperatively (P = 0.02) and do not operate on thymic hyperplasia in stage I myasthenia gravis (MG) (P = 0.04). High-volume thymoma surgeons more often use a transpleural approach for stage I thymoma < 4 cm (P = 0.01), induction therapy (P = 0.05) and are more likely to have access to a tissue bank (P = 0.04). Both in thymoma and MG surgery, cooperative prospective studies seem to be feasible in dedicated thoracic surgical associations as EACTS.

Entities:  

Mesh:

Year:  2012        PMID: 22374292      PMCID: PMC3352719          DOI: 10.1093/icvts/ivs046

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  15 in total

1.  The epidemiology of myasthenia gravis.

Authors:  Lawrence H Phillips
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

Review 2.  Chemotherapy for thymic tumors: induction, consolidation, palliation.

Authors:  Arun Rajan; Giuseppe Giaccone
Journal:  Thorac Surg Clin       Date:  2011-02       Impact factor: 1.750

Review 3.  The role of radiotherapy in the management of thymic tumors.

Authors:  Nicolas Girard; Françoise Mornex
Journal:  Thorac Surg Clin       Date:  2011-02       Impact factor: 1.750

4.  Prognostic indicators after surgery for thymoma.

Authors:  Ikenna C Okereke; Kenneth A Kesler; Mohamed H Morad; Deming Mi; Karen M Rieger; Thomas J Birdas; Sunil Badve; John D Henley; Mark W Turrentine; Robert P Nelson; Patrick J Loehrer
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

5.  International thymic malignancy interest group.

Authors:  Frank Detterbeck; Giuseppe Giaccone; Patrick Loehrer; Saul Suster; Cameron Wright
Journal:  J Thorac Oncol       Date:  2010-01       Impact factor: 15.609

6.  Standard outcome measures for thymic malignancies.

Authors:  James Huang; Frank C Detterbeck; Zuoheng Wang; Patrick J Loehrer
Journal:  J Thorac Oncol       Date:  2011-07       Impact factor: 15.609

Review 7.  Thymoma and thymic carcinoma: an update of the WHO Classification 2004.

Authors:  Philipp Ströbel; Alexander Marx; Andreas Zettl; Hans Konrad Müller-Hermelink
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

8.  Extended thymectomy for myasthenia gravis patients: a 20-year review.

Authors:  A Masaoka; Y Yamakawa; H Niwa; I Fukai; S Kondo; M Kobayashi; Y Fujii; Y Monden
Journal:  Ann Thorac Surg       Date:  1996-09       Impact factor: 4.330

9.  Thymectomy in the treatment of ocular myasthenia gravis.

Authors:  P F Roberts; F Venuta; E Rendina; T De Giacomo; G F Coloni; D M Follette; D P Richman; J R Benfield
Journal:  J Thorac Cardiovasc Surg       Date:  2001-09       Impact factor: 5.209

10.  Characterization of thymic masses using (18)F-FDG PET-CT.

Authors:  Arvind Kumar; Subodh Kumar Regmi; Roman Dutta; Rakesh Kumar; Siddhartha Datta Gupta; Prasenjit Das; Dhanapathi Halanaik; Tarun Jindal
Journal:  Ann Nucl Med       Date:  2009-07-08       Impact factor: 2.668

View more
  1 in total

Review 1.  Management of large mediastinal masses: surgical and anesthesiological considerations.

Authors:  Wilson W L Li; Wim Jan P van Boven; Jouke T Annema; Susanne Eberl; Houke M Klomp; Bas A J M de Mol
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.